TUBB4A Inhibits Glioma Development by Regulating ROS-PINK1/Parkin-Mitophagy Pathway
被引:0
|
作者:
Xi, Xueru
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Xi, Xueru
[1
]
Chen, Suqin
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Chen, Suqin
[1
]
Zhao, Xiaoli
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Zhao, Xiaoli
[1
]
Zhou, Zimu
论文数: 0引用数: 0
h-index: 0
机构:
Univ South China, Hengyang Med Coll, Canc Res Inst, Hengyang, Hunan, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Zhou, Zimu
[2
]
Zhu, Shanjie
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Zhu, Shanjie
[1
]
Ren, Xurui
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Ren, Xurui
[1
]
Wang, Xiaomei
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Wang, Xiaomei
[1
]
Wu, Jing
论文数: 0引用数: 0
h-index: 0
机构:
Peoples Liberat Army Gen Hosp, Med Ctr Chinese 1, Dept Anesthesiol, Beijing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Wu, Jing
[3
]
Mu, Shuai
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Peoples Liberat Army PLA Gen Hosp, Dept Oncol, Senior Dept Oncol, Med Ctr 1, Beijing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Mu, Shuai
[4
]
Li, Xianwen
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Li, Xianwen
[1
]
Shan, Enfang
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Shan, Enfang
[1
]
Cui, Yan
论文数: 0引用数: 0
h-index: 0
机构:
Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R ChinaNanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
Cui, Yan
[1
]
机构:
[1] Nanjing Med Univ, Sch Nursing, Nanjing, Peoples R China
[2] Univ South China, Hengyang Med Coll, Canc Res Inst, Hengyang, Hunan, Peoples R China
[3] Peoples Liberat Army Gen Hosp, Med Ctr Chinese 1, Dept Anesthesiol, Beijing, Peoples R China
[4] Chinese Peoples Liberat Army PLA Gen Hosp, Dept Oncol, Senior Dept Oncol, Med Ctr 1, Beijing, Peoples R China
Glioma is a refractory malignant tumor with a powerful capacity for invasiveness and a poor prognosis. This study aims to investigate the role and mechanism of tubulin beta class IVA (TUBB4A) in glioma progression. The differential expression of TUBB4A in humans was obtained from databases and analyzed. Glioma cells U251-MG and U87-MG were intervened by pcDNA3.1(+) and TUBB4A overexpression plasmid. MTT, CCK8, LDH, wound healing, transwell, and western blotting were used to explore whether TUBB4A participates in the development of glioma. Reactive oxygen species (ROS) were detected by the DCFH-DA probe. Mitochondrial membrane potential (MMP) was examined by JC-1. It was found that TUBB4A expression level correlated with tumor grade, IDH1 status, 1p/19q status, and poor survival in glioma patients. In addition, TUBB4A overexpression inhibited the proliferation, migration, and invasion of U251-MG and U87-MG, while increasing the degree of apoptosis. Notably, TUBB4A overexpression promotes ROS generation and MMP depolarization, and induces mitophagy through the PINK1/Parkin pathway. Interestingly, mitochondria-targeted ROS scavenger reversed the effect of TUBB4A overexpression on PINK1/Parkin expression and mitophagy, whereas mitophagy inhibitor did not affect ROS production. And the effect of TUBB4A overexpression on mitophagy and glioma progression was consistent with that of PINK1/Parkin agonist. In conclusion, TUBB4A is a molecular marker for predicting the prognosis of glioma patients and an effective target for inhibiting glioma progression by regulating ROS-PINK1/Parkin-mitophagy pathway.